{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:41:33Z","timestamp":1793137293745,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T00:00:00Z","timestamp":1457395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.vaccine.2015.12.075","type":"journal-article","created":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T05:39:46Z","timestamp":1457674786000},"page":"2971-2975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Status of vaccine research and development of vaccines for Nipah virus"],"prefix":"10.1016","volume":"34","author":[{"given":"Benjamin A.","family":"Satterfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7847-7376","authenticated-orcid":false,"given":"Brian E.","family":"Dawes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg N.","family":"Milligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.12.075_bib0195","unstructured":"World Health Organization. \u201cNipah Virus Infection\u201d, Surveillance and Outbreak Alert, Pathogenesis and Disease Fact Sheet, World Health Organization Regional Office for South-East Asia Programmes and Projects, New Delhi, India. http:\/\/www.searo.who.int\/entity\/emerging_diseases\/links\/CDS_Nipah_Virus.pdf?ua=1 [accessed 13.11.15]."},{"issue":"7","key":"10.1016\/j.vaccine.2015.12.075_bib0200","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1086\/529147","article-title":"Clinical presentation of Nipah virus infection in Bangladesh","volume":"46","author":"Hossain","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2015.12.075_bib0205","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.virusres.2011.09.026","article-title":"A review of Nipah and Hendra viruses with an historical aside","volume":"162","author":"Ksiazek","year":"2011","journal-title":"Virus Res"},{"issue":"2","key":"10.1016\/j.vaccine.2015.12.075_bib0210","first-page":"101","article-title":"Long-term socioeconomic impact of the Nipah Virus encephalitis outbreak in Bukit Pelanduk, Negeri Sembilan, Malaysia: a mixed methods approach","volume":"14","author":"Chiu Wan","year":"2009","journal-title":"Neurol Asia"},{"key":"10.1016\/j.vaccine.2015.12.075_bib0215","series-title":"A review of Hendra virus and Nipah virus infections in man and other animals. Zoonoses-infections affecting humans and animals","first-page":"997","author":"Halpin","year":"2015"},{"key":"10.1016\/j.vaccine.2015.12.075_bib0220","doi-asserted-by":"crossref","DOI":"10.3201\/eid2102.141433","article-title":"Outbreak of henipavirus infection, Philippines, 2014","author":"Ching","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2015.12.075_bib0225","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1286-4579(01)01382-X","article-title":"Laboratory diagnosis of Nipah and Hendra virus infections","volume":"3","author":"Daniels","year":"2001","journal-title":"Microbes Infect"},{"issue":"7","key":"10.1016\/j.vaccine.2015.12.075_bib0230","doi-asserted-by":"crossref","first-page":"e2739","DOI":"10.1371\/journal.pone.0002739","article-title":"Evidence of henipavirus infection in West African fruit bats","volume":"3","author":"Hayman","year":"2008","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.vaccine.2015.12.075_bib0235","doi-asserted-by":"crossref","first-page":"e25256","DOI":"10.1371\/journal.pone.0025256","article-title":"Antibodies to henipavirus or henipa-like viruses in domestic pigs in Ghana, West Africa","volume":"6","author":"Hayman","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.12.075_bib0240","first-page":"5","article-title":"Evidence for henipavirus spillover into human populations in Africa","author":"Pernet","year":"2014","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.vaccine.2015.12.075_bib0245","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.3201\/eid1508.081237","article-title":"Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001\u20132007","volume":"15","author":"Luby","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2015.12.075_bib0250","doi-asserted-by":"crossref","first-page":"e42689","DOI":"10.1371\/journal.pone.0042689","article-title":"A randomized controlled trial of interventions to impede date palm sap contamination by bats to prevent Nipah virus transmission in Bangladesh","volume":"7","author":"Khan","year":"2012","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.vaccine.2015.12.075_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/hv.3.1.3519","article-title":"Biological feasibility of developing prophylactic vaccines for viral pathogens: incubation period as a critical parameter","volume":"3","author":"Kaslow","year":"2007","journal-title":"Hum Vaccin"},{"issue":"22","key":"10.1016\/j.vaccine.2015.12.075_bib0260","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1016\/j.vaccine.2014.02.087","article-title":"Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins","volume":"32","author":"DeBuysscher","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.075_bib0265","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.antiviral.2013.10.012","article-title":"Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters","volume":"101","author":"Lo","year":"2014","journal-title":"Antivir Res"},{"issue":"31","key":"10.1016\/j.vaccine.2015.12.075_bib0270","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1016\/j.vaccine.2008.05.016","article-title":"A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats","volume":"26","author":"McEachern","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.075_bib0275","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/1743-422X-10-353","article-title":"Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease","volume":"10","author":"Mire","year":"2013","journal-title":"Virol J"},{"issue":"146","key":"10.1016\/j.vaccine.2015.12.075_bib0280","doi-asserted-by":"crossref","first-page":"146ra07","DOI":"10.1126\/scitranslmed.3004241","article-title":"A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge","volume":"4","author":"Bossart","year":"2012","journal-title":"Sci Transl Med"},{"issue":"24","key":"10.1016\/j.vaccine.2015.12.075_bib0285","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1016\/j.vaccine.2015.03.089","article-title":"Single-dose live-attenuated vesicular stomatitis virus-based vaccine protects African green monkeys from Nipah virus disease","volume":"33","author":"Prescott","year":"2015","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2015.12.075_bib0290","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.1128\/JVI.00263-06","article-title":"Recombinant Nipah virus vaccines protect pigs against challenge","volume":"80","author":"Weingartl","year":"2006","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2015.12.075_bib0295","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.virol.2012.06.001","article-title":"Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs","volume":"432","author":"Kong","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.12.075_bib0300","first-page":"197","article-title":"Immunization strategies against henipaviruses","volume":"359","author":"Broder","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2015.12.075_bib0305","first-page":"125","article-title":"Passive immunization and active vaccination against Hendra and Nipah viruses","volume":"135","author":"Broder","year":"2013","journal-title":"Dev Biol"},{"issue":"9","key":"10.1016\/j.vaccine.2015.12.075_bib0310","doi-asserted-by":"crossref","first-page":"e12709","DOI":"10.1371\/journal.pone.0012709","article-title":"The nonstructural proteins of Nipah virus play a key role in pathogenicity in experimentally infected animals","volume":"5","author":"Yoneda","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.12.075_bib0315","first-page":"6","article-title":"The immunomodulating V and W proteins of Nipah virus determine disease course","author":"Satterfield","year":"2015","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.vaccine.2015.12.075_bib0320","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/jama.1967.03130250057008","article-title":"Altered reactivity to measles virus: atypical measles in children previously immunized with inactivated measles virus vaccines","volume":"202","author":"Fulginiti","year":"1967","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.vaccine.2015.12.075_bib0325","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/9473","article-title":"Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody","volume":"5","author":"Polack","year":"1999","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.vaccine.2015.12.075_bib0330","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.vaccine.2015.12.075_bib0335","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/JVI.57.3.721-728.1986","article-title":"Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactivated virus","volume":"57","author":"Prince","year":"1986","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2015.12.075_bib0340","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/viro.2000.0340","article-title":"Molecular characterization of Nipah virus, a newly emergent paramyxovirus","volume":"271","author":"Harcourt","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.12.075_bib0345","article-title":"Phase 1 trials of rVSV Ebola vaccine in Africa and Europe: a preliminary report","author":"Agnandji","year":"2015","journal-title":"New Engl J Med"},{"issue":"9996","key":"10.1016\/j.vaccine.2015.12.075_bib0350","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.vaccine.2015.12.075_bib0355","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S1473-3099(15)00154-1","article-title":"The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1\/2 trial","volume":"15","author":"Huttner","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.12.075_bib0360","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/1743-422X-10-237","article-title":"Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months","volume":"10","author":"Pallister","year":"2013","journal-title":"Virol J"},{"issue":"242","key":"10.1016\/j.vaccine.2015.12.075_bib0365","doi-asserted-by":"crossref","first-page":"242ra82","DOI":"10.1126\/scitranslmed.3008929","article-title":"Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody","volume":"6","author":"Geisbert","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2015.12.075_bib0370","series-title":"Human clinical trials begin for deadly Hendra virus therapy","author":"Anonymous","year":"2015"},{"issue":"3","key":"10.1016\/j.vaccine.2015.12.075_bib0375","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3201\/eid2003.131159","article-title":"Hendra virus vaccine, a one health approach to protecting horse, human, and environmental health","volume":"20","author":"Middleton","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2015.12.075_bib0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2009.02.025","article-title":"Development of a neutralization assay for Nipah virus using pseudotype particles","volume":"160","author":"Tamin","year":"2009","journal-title":"J Virol Methods"},{"issue":"24","key":"10.1016\/j.vaccine.2015.12.075_bib0385","doi-asserted-by":"crossref","first-page":"12293","DOI":"10.1128\/JVI.01619-06","article-title":"Feline model of acute Nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine","volume":"80","author":"Mungall","year":"2006","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2015.12.075_bib0390","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1128\/JVI.01852-10","article-title":"Complementing defective viruses that express separate paramyxovirus glycoproteins provide a new vaccine vector approach","volume":"85","author":"Chattopadhyay","year":"2011","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2015.12.075_bib0395","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1128\/JVI.02308-14","article-title":"Rhabdovirus-based vaccine platforms against henipaviruses","volume":"89","author":"Kurup","year":"2015","journal-title":"J Virol"},{"issue":"30","key":"10.1016\/j.vaccine.2015.12.075_bib0400","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1016\/j.vaccine.2006.11.066","article-title":"Development and registration of recombinant veterinary vaccines: the example of the canarypox vector platform","volume":"25","author":"Poulet","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2015.12.075_bib0405","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/infdis\/jis699","article-title":"Protection against henipavirus infection by use of recombinant adeno-associated virus-vector vaccines","volume":"207","author":"Ploquin","year":"2013","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2015.12.075_bib0410","doi-asserted-by":"crossref","first-page":"e58414","DOI":"10.1371\/journal.pone.0058414","article-title":"Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge","volume":"8","author":"Yoneda","year":"2013","journal-title":"PLOS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2015.12.075_bib0415","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.vaccine.2010.10.053","article-title":"Induction of neutralizing antibodies to Hendra and Nipah glycoproteins using a Venezuelan equine encephalitis virus in vivo expression system","volume":"29","author":"Defang","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2015.12.075_bib0420","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1128\/JVI.78.2.834-840.2004","article-title":"Nipah virus: vaccination and passive protection studies in a hamster model","volume":"78","author":"Guillaume","year":"2004","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2015.12.075_bib0425","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1128\/JVI.80.4.1972-1978.2006","article-title":"Antibody prophylaxis and therapy against Nipah virus infection in hamsters","volume":"80","author":"Guillaume","year":"2006","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2015.12.075_bib0430","doi-asserted-by":"crossref","first-page":"e1000642","DOI":"10.1371\/journal.ppat.1000642","article-title":"A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute Nipah virus infection","volume":"5","author":"Bossart","year":"2009","journal-title":"PLoS Pathog"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16002966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16002966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:51:16Z","timestamp":1600303876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16002966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":48,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0264410X16002966"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.075","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Status of vaccine research and development of vaccines for Nipah virus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 World Health Organization; licensee Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}